We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

TriLink BioTechnologies Announces Agreement with American Cleanroom Systems to build cGMP Facility


Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "TriLink BioTechnologies Announces Agreement with American Cleanroom Systems to build cGMP Facility"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:
 

The pharmaceutical cGMP production facility will contain nine labs and be equipped to manufacture and process mRNA, long RNA, aptamers, oligonucleotides, small molecules and nucleoside triphosphates. The project is scheduled to be complete in the first quarter of next year.

"Building a pharmaceutical cGMP production facility is the next logical step in expanding our quality system. Soon we will be able to support our customers at every stage from research to clinical trials and commercialization," said TriLink CEO, Richard Hogrefe, Ph.D. "ACS offered the quality and experience we were seeking and we're confident they are the right contractor to help us meet these goals."

Advertisement